TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00589784

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib
Description: The study drug will be administered on an outpatient basis. The starting dose will be 50 mg daily for 28 days (4 consecutive weeks) followed by 14 days off for patients not on CYP3A4 inducers or inhibitors. A cycle equals 42 days.
Study: NCT03986632

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tundra Gifts
Description: Tundra Gifts is a home-focused intervention delivered by community health workers (CHW) that focuses on promoting healthy eating and an active lifestyle among 3-5 year olds through family and community partnerships. Primary caregivers will attend monthly interactive education session, receive a monthly gift basket that includes resources and supplies to support behavior change at home and receive ongoing social support through a Facebook site.
Study: NCT02391896

Intervention type: DEVICE
Group type: OTHER
Intervention: Dual energy and tomosynthesis xray

Intervention type: DEVICE
Group type: OTHER
Intervention: Dual energy and tomosynthesis xray
Study: NCT02157207

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Antioxidant
Description: Comparison of antioxidant supplementation with a placebo. Effects of race and age and race in repsonse to the supplementation will be evaluated.
Study: NCT01880476

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home visits and group program
Description: Participants will receive up to three home visits by a Registered Nurse and two home visits by a Registered Dietitian over the 6-month intervention period. Participants will also be invited to attend a monthly Diabetes Wellness Day group program which will include diabetes education, interaction with peer volunteers, group exercise, and a meal. The Registered Nurse will coordinate care to help participants access necessary community supports and services and lead monthly interprofessional case conferences to develop a client-centred plan of care for each study participant.
Study: NCT02157207

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Antioxidant
Description: Comparison of antioxidant supplementation with a placebo. Effects of race and age and race in repsonse to the supplementation will be evaluated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Comparison of antioxidant supplementation with a placebo. Effects of race and age and race in repsonse to the supplementation will be evaluated.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Comparison of antioxidant supplementation with a placebo. Effects of race and age and race in repsonse to the supplementation will be evaluated.
Study: NCT02964403

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cox-2

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin
Study: NCT01152554

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TC-5214
Description: Tablet, oral, twice daily for 52 weeks
Study: NCT05867342

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrin
Description: Topical application of 2 pieces of Epinephrin (1:1,000)-soaked cottonoid in nasal cavity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrin 1:100,000
Description: 4 ml intranasal infiltration of 1% lidocaine with epinephrine (1:100,000) at 2 sites (2 ml infiltration at each site)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: 4 ml intranasal infiltration of saline at 2 sites (2 ml infiltration at each site)
Study: NCT02758977

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ALPPS
Description: For detailed information please refer to description of experimental arm
Study: NCT01152554

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet, oral, twice daily for 52 weeks
Study: NCT00443469

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: magnetic stimulation
Description: SMS was delivered with a repetitive magnetic stimulator connected to a figure of eight coil capable of delivering a maximum output of 2 Tesla per pulse. The coil measured 90 mm in each wing and was centered over the surface landmark corresponding to the cauda equina region. SMS was performed with the patient lying comfortably in the prone position and a soft pillow supported the lower abdomen. The coil was placed flat over the back with the handle pointing cranially. Each patient on active treatment received 200 trains of 5 pulses delivered at 10 Hz, at an interval of 5 s between each train. As this was a pilot study, each only received 1000 pulses in a single session.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Magnetic Stimulation with tilted coil
Description: The placebo arm consisted of 'sham' SMS delivered with the coil angled vertically and one of the wing edges in contact with the stimulation point. As this coil type allows maximum magnetic flux at the center of the intersection, we believe minimum or no stimulation was effected at the edge of the coil in contact with the patient. Stimulation parameters and duration were unchanged in this arm.
Study: NCT04368195

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector spinae block
Description: Erector Spinae Plane Block (ESPB) - first recently described for the treatment of thoracic neuropathic pain, is a peri-paravertebral regional anesthesia technique that has since been reported as an effective technique for prevention of postoperative pain in various surgeries (10-12). In ESPB, local anesthetic is reported to be administered in to the interfascial plane between the transverse process of the vertebra and the erector spinae muscles, spreading to multiple paravertebral spaces.
Study: NCT00801593

Intervention type: PROCEDURE
Intervention: Steroid injection into the TMJs.
Description: In case of otherwise noncontrollable TMJ involvement steroids are injected into arthritic TMJs under MRI guidance.
Study: NCT01893528

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN2009

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN2009

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN2009

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Study: NCT02071095

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arm A: Poly-ICLC
Description: Poly-ICLC (Hiltonol®, Oncovir) Administration - On days 1 and 2, patients randomized to this arm will be injected subcutaneously in the arm with 1.4 mg of Poly-ICLC (Hiltonol®, Oncovir). Each subject will receive a total of 2 SC doses of Poly-ICLC. The volume of each injection is 0.7ml. The investigators who are blinded will not be present at the time of injection by the study nurse.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Arm B: Normal Saline
Description: Normal Saline - On days 1 and 2, patients randomized to this arm will be injected subcutaneously in the arm with normal saline obtained from the Rockefeller University Pharmacy. Each subject will receive a total of 2 SC doses of normal saline. The volume of each injection is 0.7ml. The investigators who are blinded will not be present at the time of injection by the study nurse.
Study: NCT02945020

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate mesylate
Description: Participants will receive dabigatran etexilate mesylate 75 mg, orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Odalasvir (ODV)
Description: Participants will receive ODV 25 mg, orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simeprevir (SMV)
Description: Participants will receive SMV 75 mg, orally.
Study: NCT03354988

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical exercise group
Description: For the exercise group, systematic physical activity programs consisting of range-of-motion exercises with gentle compression, extension and flexion of all joints of both bilateral upper extremities; including the shoulder, elbow, and wrist and lower extremities; including the hip, knee and ankle, with a total of 12 joints. Each activity was about 10 min a day and was carried out 5 times per week for 4 weeks. This program was started after 1 week of birth. Physical activity continued until discharge from hospital

Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: Other routine care activities such as bathing (every day) and kangaroo care (30 minutes/day), will be done for both the control
Study: NCT00657111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-8958 formulated as dry powder
Description: CS-8958, formulated as a dry-powder and will be administered from capsules containing 5 mg CS-8958 and lactose to 25 mg (placebo) inserted into a FlowCaps inhaler device.
Study: NCT02758977

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TWO STAGE HEPATECTOMY
Description: For detailed information please refer to description of active comparator arm
Study: NCT01135576

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: non-fortified fruit juices consumed as part of the usual diet

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Iron fortified fruit juice
Description: Consumption of micronized iron pyrophosphate supplemented fruit juices as part of the usual diet
Study: NCT04499547

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: YouTube-delivered aerobic and muscle-strengthening physical activity intervention
Description: Participants in the intervention group will receive two YouTube-delivered videos each week, for 8 weeks. In detail, on Monday, participants will receive an aerobic-based physical activity video with information and a workout to complete and on Thursdays, the participants will receive a video with muscle-strengthening physical activity information and a workout to complete.
Study: NCT02125643

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Flour
Description: Flour will be administered as the placebo.
Study: NCT01404351

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEAK PlasmaBlade

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scalpel and Traditional Electrosurgery
Study: NCT00396747

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab, methylprednisolone, methotrexate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab, methylprednisolone, methotrexate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab, methylprednisolone, methotrexate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate + Methylprednisolone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate + Infliximab
Study: NCT00571376

Intervention type: OTHER
Intervention: Health information technology and exchange
Description: Health information technology includes electronic health records, electronic prescribing, and electronic results notification and/or viewers. Health information exchange includes use of central repositories of data and peer-to-peer models.
Study: NCT05953714

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: incision side cleaning with antiseptic products
Description: A pilot study was conducted with six pregnant women to clarify the use of the data collection tools and the implementation plan during the study process. After that, the data collection forms were finalized. In the 6 operating room, two different solutions (PI and CG) were applied, according to the preference of the physician, to clean the surgical field. The study was carried out by adding a CG shower application to the physician's preferred solution (for a total of 3 groups). Pregnant women who were admitted to the obstetrics clinic were informed about the purpose, scope, duration, and method of the study by one of the researchers. Follow-up of the women was done for 7 day duration following postnatal to assess postoperative for comfort, pain, wound complications by the nurse researcher. At discharge, cultures were taken from the abdominal wounds of the participants

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: incision side cleaning with antiseptic products
Description: A pilot study was conducted with six pregnant women to clarify the use of the data collection tools and the implementation plan during the study process. After that, the data collection forms were finalized. In the 6 operating room, two different solutions (PI and CG) were applied, according to the preference of the physician, to clean the surgical field. The study was carried out by adding a CG shower application to the physician's preferred solution (for a total of 3 groups). Pregnant women who were admitted to the obstetrics clinic were informed about the purpose, scope, duration, and method of the study by one of the researchers. Follow-up of the women was done for 7 day duration following postnatal to assess postoperative for comfort, pain, wound complications by the nurse researcher. At discharge, cultures were taken from the abdominal wounds of the participants
Study: NCT03408730

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hepatitis B Vaccination
Description: Hepatitis B Vaccination

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B Vaccination
Description: Hepatitis B Vaccination

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B Vaccination
Description: Hepatitis B Vaccination

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B Vaccination
Description: Hepatitis B Vaccination
Study: NCT01085981

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%
Description: On the first office visit the patient will have their baseline clitoral and uterine blood flow measured quantitatively by the same sonographer using the General electric Voluson 700 unit. Clitoral blood flow will be accessed utilizing the 12 megahertz linear probe. With light pressure, the probe will be applied sagittally and proximal to the clitoral hood with an angle less than 20 degrees. Peak clitoral artery systolic and end diastolic velocity will be measured and resistive index values will be recorded. Then utilizing the 7.5 megahertz vaginal probe baseline uterine artery flow measurements will also be obtained and recorded. With both GRAS cream and placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%
Description: On the first office visit the patient will have their baseline clitoral and uterine blood flow measured quantitatively by the same sonographer using the General electric Voluson 700 unit. Clitoral blood flow will be accessed utilizing the 12 megahertz linear probe. With light pressure, the probe will be applied sagittally and proximal to the clitoral hood with an angle less than 20 degrees. Peak clitoral artery systolic and end diastolic velocity will be measured and resistive index values will be recorded. Then utilizing the 7.5 megahertz vaginal probe baseline uterine artery flow measurements will also be obtained and recorded. With both GRAS cream and placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical study cream
Description: One gram applied to clitoris by nurse then ten minutes later doppler study of clitoral blood flow

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GRAS cream
Description: 1 gram of active cream will be applied by nurse then 10 minutes later clitoral blood flow will be assessed by doppler studies see protocol
Study: NCT04107064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NaW
Description: Participants will receive assistance with finding employment, onboarding, training, and so on.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NaW-DS
Description: Participants will receive assistance with onboarding and training 6 months after the initiation of their employment.
Study: NCT01492439

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation
Description: The George Brown College Redirection Through Education (RTE) is a supported education program, offered at no fee to students, that facilitates entry into formal education and employment for persons with mental illness. In addition to the supports available to all RTE students, this group will receive a total of twenty 45 minute computer-based cognitive exercise sessions held twice a week using COGPACK (Ver 6.0,www.cogpack.de). This program facilitates practice across a range of cognitive functions, including attention,psychomotor speed,memory, and executive functions. Participants will also take part in 10 weekly group discussion sessions,approximately 60 minutes in duration, focusing on strategies for management of symptoms and other cognitive deficits in an academic setting.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supported Education
Description: Students enroll in credit courses, such as communications, computer skills, and the psychology of human relations which can lead to eligibility for post-secondary programs. Remedial skills in English, supervised study skills classes and other non-credit courses are included. Vocational testing is offered to help students determine their interests and aptitudes and students try out possible careers as well as their readiness to return to work by engaging in volunteer and work placements. Counsellors are also available to assist students in areas such as learning difficulties and coping with the stresses of school. The overarching goal of this program is to help students explore valued non-illness identities, build confidence, and re-engage with their communities.
Study: NCT03513549

Intervention type: DRUG
Intervention: Loxapine 10 MG
Study: NCT03643731

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HeatTens (HV-F311-E)
Description: Patients need to apply the device during 30 minutes.
Study: NCT02870686

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ERCP without the use of fluoroscopy
Description: ERCP removal of stone technique without the use of fluoroscopy involves: (1) catheter with wire achieve bile duct, (2) confirmation of bile duct achievement with catheter aspiration of bile, (3) performance of endoscopic biliary sphinctertome, (4) stone removal with balloon or basket- number of stones removed should compare number detected on EUS, (5) confirmation of complete stone clearance with radiocontrast.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ERCP with the use of fluoroscopy
Description: ERCP removal of stone technique with the use of fluoroscopy involves: (1) catheter with wire achieve bile duct, (2) confirmation of bile duct achievement with fluoroscopy images, (3) performance of endoscopic biliary sphinctertome, (4) stone removal with balloon or basket, (5) confirmation of complete stone clearance with radiocontrast.
Study: NCT04385511

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: supraglottic jet ventilation
Description: patients who were randomized into supraglottic jet ventilation group would be placed Wei Nasal Jet Tube after conducted. Then they will get the supraglottic jet ventilation to make sure their pulse oximetry is over 95%. After 3 minutes, endotracheal intubation was performed via mouth approach.
Study: NCT03008005

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Capsule
Description: Placebo is administered only once (approximately 120 min prior to MR scanning in Visit 3) by the oral route and contains only dextrose in opaque capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronabinol Cap 5 milligrams (MG)
Description: Dronabinol (5mg) is administered only once (approximately 120 min prior to MR scanning in Visit 3) by the oral route and is placed in an opaque capsule with dextrose filler.
Study: NCT03430973

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: Lyrics and tempo of music will be manipulated to increase or decrease aggressive driving.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Roadside vegetation
Description: The roadside will contain trash to increase aggressive driving, or vegetation to decrease aggressive driving. There is also a control group.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video game
Description: Participants will play a racing or neutral video game before driving in the simulator.
Study: NCT00657111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-8958 formulated as dry powder
Description: CS-8958, formulated as a dry-powder and will be administered from capsules containing 5 mg CS-8958 and lactose to 25 mg (placebo) inserted into a FlowCaps inhaler device.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-8958 formulated as dry powder
Description: CS-8958, formulated as a dry-powder and will be administered from capsules containing 5 mg CS-8958 and lactose to 25 mg (placebo) inserted into a FlowCaps inhaler device.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-8958 formulated as dry powder
Description: CS-8958, formulated as a dry-powder and will be administered from capsules containing 5 mg CS-8958 and lactose to 25 mg (placebo) inserted into a FlowCaps inhaler device.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsules containing 25 mg lactose

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsules containing 25 mg lactose

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsules containing 25 mg lactose

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsules containing 25 mg lactose
Study: NCT02319447

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Additional education
Description: Our Intervention includes a 60-90 minute educational seminar, entitled Destination: Transplant, featuring live speakers, delivered to small groups of Black kidney transplant candidates and their family and friends. Topics include: 1) basic facts about Chronic Kidney Disease (CKD), transplant, and the waiting list; 2) the experience of receiving a LDKT transplant (by a Black LDKT recipient); 3) the experience of serving as a living kidney donor (by a Black living kidney donor); and 4) strategies to increase the chances of getting a transplant sooner. Participants receive monthly mailed, written information for 9 months and a follow-up phone call from a transplant educator, 3 months after attending the seminar.
Study: NCT04220047

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left Atrial Appendage Resection and Marshall Ligament Amputation
Description: Left Atrial Appendage Resection and Marshall Ligament Amputation during the cardiac surgery